SVA Stock Price Prediction 2026-2027
AI-powered forecast for Sinovac Biotech Ltd
Based on Wall Street consensus estimate - Medium Confidence
Current Price
$6.47
Price Targets for 2027
Bear Case
$2.99
-53.8%
Base Case
$3.52
-45.6%
Bull Case
$4.05
-37.4%
Prediction Tracking
Coming Soon for SVA
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for SVA
Key Factors Influencing SVA Stock
Bullish Factors
- Revenue growth of 3.0% year-over-year
- Market position and competitive advantages
Risk Factors
- Bear case implies 54% downside risk
- Market volatility and macroeconomic factors
- Competitive pressures in Biotechnology
Prediction Methodology
These predictions are based on the Wall Street consensus price target of $3.52.
Bull and bear cases are calculated with a reasonable spread around the consensus based on historical volatility.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for SVA
Frequently Asked Questions
What is SVA stock price today?
SVA (Sinovac Biotech Ltd) stock is trading at $6.47 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is SVA stock going up or down today?
SVA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy SVA stock now?
The decision to buy SVA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is SVA a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for SVA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is SVA stock overvalued or undervalued?
SVA currently trades at a P/E ratio of 6.66, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if SVA is fairly priced.
What is SVA's P/E ratio?
SVA has a price-to-earnings (P/E) ratio of 6.66, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is SVA's market cap?
SVA (Sinovac Biotech Ltd) has a market capitalization of $0.64 billion, making it a small-cap stock.
What is SVA's price to book ratio?
SVA trades at a price-to-book (P/B) ratio of 1.82, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Does SVA pay dividends?
Yes, SVA pays dividends with a current yield of 8.50%. Dividend payments provide income for investors in addition to potential stock price appreciation.
What is SVA's dividend yield?
SVA's dividend yield is 8.50%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.
Is SVA stock a good long-term investment?
SVA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is SVA's revenue growth rate?
SVA has shown revenue growth of 3.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.
Is SVA profitable?
Yes, SVA is profitable with a profit margin of 0.2%. This indicates the company generates 0.2 cents of profit for every dollar of revenue.
What are the risks of investing in SVA?
Key risks for SVA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does SVA compare to its competitors?
Compare SVA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize SVA's performance and positioning.
What is SVA's stock price target for 2026?
Our AI model provides price targets for SVA based on fundamental analysis: Bull case $8.41 (+30%), Base case $7.44 (+15%), Bear case $5.82 (-10%). Visit our prediction page for detailed forecasts.
What do analysts say about SVA?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for SVA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is SVA's next earnings report?
SVA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.